SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCM.L Regulatory News (MCM)

  • There is currently no data for MCM

Appendix 3Y

27 Jun 2012 10:17

RNS Number : 2494G
Coal of Africa Limited
27 June 2012
Β 

ο»Ώ

Rule 3.19A.2

Appendix 3Y

Β 

Change of Director's Interest Notice

Β 

This announcement replaces that of 07:11 on 29 July 2011. The replacement is to reflect the fact that the price per share disposed of was 73 pence and not 73 cents.

Β 

Β 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Β 

Name of entity Coal of Africa Limited

ABN 98 088 905 388

Β 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Β 

Name of Director

Simon James Farrell

Date of last notice

30 June 2011

Β 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Β 

Direct or indirect interest

Indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

Β 

Newcove International Inc.

Β 

Mr Farrell is a director and shareholder of Newcove International Inc.

Date of change

26 June 2012

No. of securities held prior to change

Direct interest

5,000,000 options exercisable at $1.25 each on or before 30 September 2012.

3,000,000 options exercisable at $2.74 each on or before 30 November 2014.

Indirect interest

2,871,791 fully paid ordinary shares.*

*Shares are held by Newcove International Inc, of which Mr Farrell is a director and shareholder.

Class

Shares

Number acquired

1,833,150

Number disposed

Nil

Β 

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

Β 

Nil

No. of securities held after change

Direct interest

5,000,000 options exercisable at $1.25 each on or before 30 September 2012.

3,000,000 options exercisable at $2.74 each on or before 30 November 2014.

Indirect interest

4,704,941 fully paid ordinary shares.*

Β 

*Shares are held by Newcove International Inc, of which Mr Farrell is a director and shareholder.

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Issue of shares to Directors as approved at the general meeting of shareholders held on 22 June 2012.

Β 

Part 2 - Change of director's interests in contracts

Β 

Detail of contract

N/A

Nature of interest

Β 

Β 

Name of registered holder

(if issued securities)

Β 

Date of change

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

Β 

Interest acquired

Interest disposed

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

Β 

Interest after change

Β 

Β 

Β 

Β 

Β 

Part 3 - +Closed period

Β 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

Β 

If prior written clearance was provided, on what date was this provided?

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEANKXAFSAEEF
Date   Source Headline
24th Jan 20249:30 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20238:32 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20237:30 amRNSOperations & Trading Update
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
18th Dec 20233:02 pmRNSREVISED NON-BINDING AND INDICATIVE PROPOSAL
30th Nov 20232:31 pmRNSResult of Annual General Meeting
27th Nov 20233:03 pmRNSAnnual General Meeting Details
8th Nov 20237:15 amRNSIssue of Equity
2nd Nov 20231:15 pmRNSReceipt of Notice of Intention to Make a Takeover
31st Oct 20232:30 pmRNSDespatch of Annual Report and Notice of AGM
31st Oct 20239:25 amRNSActivities Report for the Quarter Ended 30 Sep 23
31st Oct 20239:25 amRNSAppendix 5B
27th Oct 202310:30 amRNSIssue of Equity
5th Oct 202310:30 amRNSAnnual General Meeting Details
21st Sep 202312:13 pmRNSResults for the Full Year Ended 30 June 2023
15th Sep 202310:10 amRNSChange of Australian Share Registry Address
31st Jul 20239:35 amRNSAppendix 5B
31st Jul 20239:33 amRNSACTIVITIES REPORT FOR QUARTER ENDED 30 JUNE 2023
25th Jul 20237:45 amRNSIDC Extension Announcement
30th Jun 202312:15 pmRNSTrading Update
28th Apr 20239:35 amRNSAppendix 5B
28th Apr 20239:30 amRNSActivities Report for the Quarter Ended 31 Mar 23
27th Apr 20239:00 amRNSHolding(s) in Company
26th Apr 202311:20 amRNSMakhado Project Update
31st Mar 20238:02 amRNSIssue of Shares Under the Performance Rights Plan
16th Mar 20237:00 amRNSChange of JSE Sponsor
15th Mar 20237:40 amRNSInterim Financial Report
15th Mar 20237:40 amRNSHalf-year Results
10th Mar 20231:00 pmRNSDirector Appointments & Resignation
22nd Feb 20232:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20237:31 amRNSAppendix 5B
31st Jan 20237:30 amRNSActivities Report for the Quarter Ended 31 Dec 22
19th Jan 20232:15 pmRNSGrant of Options & Performance Rights to Directors
23rd Dec 20228:37 amRNSOutsourcing of the Vele Aluwani Colliery
20th Dec 20223:00 pmRNSExtension of Coal Sales & Marketing Agreement
1st Dec 20229:00 amRNSIDC Loan Update
30th Nov 20224:32 pmRNSResult of AGM
11th Nov 20226:20 pmRNSDirectors' Dealings
4th Nov 20222:06 pmRNSSecond Price Monitoring Extn
4th Nov 20222:00 pmRNSPrice Monitoring Extension
4th Nov 202210:00 amRNSFully Underwritten Rights Issue Offer Closes
31st Oct 20229:31 amRNSAppendix 5B
31st Oct 20229:30 amRNSActivities Report for the Quarter Ended 30 Sep 22
31st Oct 20227:00 amRNSDespatch of Annual Report and Notice of AGM
7th Oct 202211:07 amRNSAnnual General Meeting Details
30th Sep 20229:45 amRNSResults for the Full Year Ended 30 June 2022
28th Sep 20222:05 pmRNSSecond Price Monitoring Extn
28th Sep 20222:00 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSFully Underwritten A$40M Rights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.